-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Kinnate Biopharma Inc. annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate from 2020 to 2023.
- Kinnate Biopharma Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2023 was $55.4M.
- Kinnate Biopharma Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $110M.
- Kinnate Biopharma Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$6.83M, a 96.2% increase from 2021.
- Kinnate Biopharma Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$181M, a 469% decline from 2020.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)